Table 3.
ARM | AZB | BLR | GEO | KGZ | MDA | TJK | TUR | UZB | ||
---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | Age | |||||||||
18–29a | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
30–44 | 1.02 (0.70–1.49) | 0.94 (0.74–1.20) | 1.07 (0.79–1.45) | 0.71 (0.48–1.14) | 1.22 (0.73–2.04) | 0.98 (0.70–1.39) | 1.01 (0.69–1.46) | 0.99 (0.77–1.22) | 0.77 (0.61–0.97) | |
45–59 | 1.14 (0.78–1.66) | 1.02 (0.80–1.29) | 1.11 (0.89–1.50) | 1.13 (0.76–1.69) | 1.60 (0.96–2.66) | 1.08 (0.78–1.50) | 0.95 (0.65–1.39) | 1.04 (0.83–1.30) | 1.22 (0.95–1.57) | |
60–69 | 1.40 (0.94–2.08) | 1.78 (1.37–2.31) | 2.47 (1.82–3.34) | 1.55 (1.03–2.33) | 2.95 (1.66–5.24) | 1.79 (1.29–2.50) | 2.74 (1.74–4.31) | 1.91 (1.48–2.47) | 2.42 (1.61–3.63) | |
P-value | 0.2 | <0.0001* | <0.0001* | 0.001* | <0.0001* | <0.0001* | <0.0001* | <0.0001* | <0.0001* | |
OR (95% CI) | Gender | |||||||||
Mena | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Women | 0.81 (0.63–1.05) | 1.01 (0.86–1.16) | 0.89 (0.76–1.06) | 1.07 (0.85–1.36) | 1.26 (0.94–1.71) | 0.84 (0.69–1.03) | 1.76 (1.37–2.27) | 2.15 (1.86–2.50) | 2.11 (1.75–2.56) | |
P-value | 0.1 | 0.9 | 0.2 | 0.5 | 0.1 | 0.09 | <0.0001* | <0.0001* | <0.0001* | |
OR (95% CI) | Education | |||||||||
<6 yearsa | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
6–12 years | 0.47 (0.21–1.01) | 0.88 (0.59–1.33) | 0.73 (0.59–0.89) | 0.92 (0.45–1.88) | 0.99 (0.64–1.56) | 0.69 (0.53-0.88) | 0.42 (0.30–0.60) | 0.93 (0.75–1.16) | 1.16 (0.87–1.55) | |
>12 years | 0.36 (0.16–0.80) | 0.83 (0.55–1.25) | 1.30 (1.03–1.65) | 1.00 (0.49–2.04) | 1.20 (0.71–2.02) | 0.83 (0.60–1.14) | 0.38 (0.26–0.55) | 0.85 (0.66–1.08) | 0.81 (0.60–1.09) | |
P-value | 0.02 | 0.5 | <0.0001* | 0.7 | 0.6 | 0.008* | <0.0001* | 0.4 | 0.001 | |
OR (95% CI) | Household status | |||||||||
Not living alonea | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Living alone | 1.33 (1.04–1.72) | 1.19 (1.01–1.41) | 0.98 (0.83–1.14) | 1.42 (1.13–1.77) | 1.15 (0.74–1.58) | 1.09 (0.89–1.36) | 0.96 (0.68–1.35) | 1.09 (0.92–1.28) | 0.88 (0.71–1.10) | |
P-value | 0.03* | 0.04* | 0.8 | 0.002* | 0.4 | 0.4 | 0.8 | 0.3 | 0.3 | |
OR (95% CI) | Monthly income | |||||||||
Q1a | 1 | 1 | N/A | 1 | 1 | 1 | 1 | 1 | N/A | |
Q2 | 1.59 (1.13–2.24) | 1.18 (0.96–1.45) | N/A | 0.83 (0.62–1.13) | 0.81 (0.56–1.17) | 1.01 (0.77–1.33) | 1.07 (0.76–1.51) | 0.91 (0.74–1.11) | N/A | |
Q3 | 1.22 (0.88–1.71) | 1.15 (0.93–1.44) | N/A | 1.07 (0.80–1.44) | 0.84 (0.56–1.27) | 0.92 (0.68–1.24) | 0.99 (0.67–1.47) | 1.30 (1.06–1.60) | N/A | |
Q4 | 0.86 (0.60–1.25) | 1.45 (1.19–1.78) | N/A | 1.08 (0.80–1.48) | 1.20 (0.81–1.77) | 0.98 (0.72–1.34) | 1.05 (0.74–1.47) | 1.39 (1.12–1.73) | N/A | |
P-value | 0.003* | 0.004* | 0.4 | 0.2 | 0.9 | 0.9 | <0.0001* |
ARM: Armenia; AZB: Azerbaijan; BLR: Belarus; GEO: Georgia; KGZ: Kyrgyzstan; MDA: Moldova; TJK: Tajikistan; TUR: Turkey; UZB: Uzbekistan; N/A: not available.
Reference category; P-values for the statistical significance of the trend in risk assessed by the Wald chi-squared test.
Statistically significant value for P < 0.05; all analyses were adjusted for body mass index.